Home > Products > API > Cefpiramide sodium
Cefpiramide sodium
  • Cefpiramide sodiumCefpiramide sodium

Cefpiramide sodium

Product Name:Cefpiramide sodium
Formulae hypotheticae: C25H25N8NaO7S2
M. Pondus: 636.63
CAS Subcriptio Number; 74849-93-7

Model:CAS NO:74849-93-7

Mitte Inquisitionem

depictio producti

Cefpiramide sodium

Product nomen:Natrium Cefpiramide 74849-93-7
CAS No:74849-93-7
Specification: in domo

Nomen Cefpiramide sodium
Synonyma SM-1652; WY-44635;Sodium(6R,7R)-7-[[(2R)-2-(4-hydroxyphenyl)-2-[(6-methyl-4-oxo-1H-pyridine-3-carbonyl. )amino]acetyl]amino]-3-[ (1-methyltetrazol-5-yl)sulfanylmethyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylato;5-Thia-1-azabicyclo[4.2.0Chemic albook]oct-2-ene-2-carboxylicacid,7-[[[[(4-hydroxy-6-methyl-3-pyridinyl)carbonyl]amino](4-hydroxyphenyl)acetyl]amino]-3-[[( 1-m ethyl-1H-tetrazol-5-yl)thio]methyl]-8-oxo-,monosodiumsalt[6R-[6α,7β(R*)]]-;AntibioticSM1652;Cefpiran;Sepatren;SM1652;Suncefal
copyRight
M. Structure CAS # 59-02-9, Vitamin E, D-alpha-Tocopherol, (2R)-3,4-Dihydro-2,5,7,8-tetramethyl-2-[(4R,8R)-4,8,12-trimethyltridecyl]-2H-1-benzopyran-6-ol
Formulae hypotheticae C25H25N8NaO7S2
M. Pondus 636.63
CAS Subcriptio Number 74849-93-7


Tractantem et repono
Cautiones pro tutum pertractatio
Bene ventilatas tractantem in loco. Apta tutela vestitus. Pelle et oculis contactum fuge. Fuge formationem pulveris et aerosols. Utere instrumentis non-noctis. Ne ignis per electrostatic missionem vaporis.
Conditiones repono pro tuto, inter quaslibet incompatibilitates
Repone continens arcte clausum in loco sicco, frigido et bene ventilato. Disponunt a vasis victualibus vel materiae repugnantibus.

Imprimis usus finis (s): oeconomiae laboratoriae, ad investigationes scientificas et evolutionem tantum



Hot Tags: Natrium Cefpiramide, China, Suppliers, Manufacturers, Factory
Related Categoria
Mitte Inquisitionem
Libenter placet, ut inquisitionem tuam in forma infra exhibeas. Respondebimus tibi in 24 horis.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept